Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pentoxifylline, fibrinogen and leukocytes.

J Soria1, M L Giovannangeli, I E Jolchine

  • 1Laboratoire Sainte Marie, Hotel Dieu, Paris, France.

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|October 1, 1990
PubMed
Summary

Pentoxifylline therapy reduced plasma fibrinogen levels in arteritis patients, correlating with symptom improvement. This effect in patients, unlike healthy volunteers, suggests an indirect mechanism possibly linked to reduced TNF synthesis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First Constraint on Atmospheric Millicharged Particles with the LUX-ZEPLIN Experiment.

Physical review letters·2025
Same author

New Constraints on Cosmic Ray-Boosted Dark Matter from the LUX-ZEPLIN Experiment.

Physical review letters·2025
Same author

Dark Matter Search Results from 4.2  Tonne-Years of Exposure of the LUX-ZEPLIN (LZ) Experiment.

Physical review letters·2025
Same author

Constraints on Covariant Dark-Matter-Nucleon Effective Field Theory Interactions from the First Science Run of the LUX-ZEPLIN Experiment.

Physical review letters·2024
Same author

First Dark Matter Search Results from the LUX-ZEPLIN (LZ) Experiment.

Physical review letters·2023
Same author

Study of dielectric breakdown in liquid xenon with XeBrA: The xenon breakdown apparatus.

The Review of scientific instruments·2023

Area of Science:

  • Pharmacology
  • Immunology
  • Vascular Medicine

Background:

  • Pentoxifylline is known to affect plasma fibrinogen levels.
  • Arteritis patients often exhibit elevated fibrinogen levels, contributing to vascular inflammation and disease progression.
  • The precise mechanism by which pentoxifylline influences fibrinogen in arteritis remains unclear.

Purpose of the Study:

  • To investigate the effect of pentoxifylline on plasma fibrinogen levels in patients with arteritis.
  • To explore the relationship between changes in fibrinogen and clinical symptom improvement during pentoxifylline therapy.
  • To compare the effects of pentoxifylline on fibrinogen in arteritis patients versus healthy volunteers.

Main Methods:

  • Ex vivo experiments were conducted on both healthy volunteers and patients diagnosed with arteritis.

Related Experiment Videos

  • Plasma fibrinogen levels were monitored during pentoxifylline administration.
  • Clinical symptoms in arteritis patients were assessed and correlated with fibrinogen level changes.

    • Main Results:

    • Pentoxifylline therapy confirmed a significant decrease in plasma fibrinogen levels in arteritis patients.
    • The reduction in fibrinogen levels was positively correlated with the improvement of clinical symptoms in these patients.
    • No significant modifications in plasma fibrinogen levels were observed in healthy volunteers receiving pentoxifylline.

    Conclusions:

    • The observed decrease in fibrinogen in arteritis patients is likely mediated by an indirect mechanism.
    • Pentoxifylline's potential role in reducing Tumor Necrosis Factor (TNF) synthesis may contribute to the observed fibrinogen reduction.
    • These findings suggest pentoxifylline as a potential therapeutic agent for managing fibrinogen levels and associated symptoms in arteritis.